Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Eisai

Status: Completed

Conditions: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive

Treatments: Drug: Rabeprazole Sodium

Study type: Observational

Funder types: Industry

Identifiers

NCT01264822

PRT10T

Details and patient eligibility

About

To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori

Enrollment: 108 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• gastric low-grade mucosa-associated lymphoid tissue (MALT) lymphoma with Helicobacter pylori positive
• The stages of MALT lymphoma are Lugano International Conference classification Stage I or II 1 and Wotherspoon grade 4 or 5

Exclusion criteria

• With diffuse large B-cell lymphoma
• Have been treated to gastric mucosa-associated lymphoid tissue (MALT) lymphoma
• Corresponding to contraindication of each drug

Trial design

108 participants in 1 patient group

Treatment Arm 1 Rabeprazole Sodium

Treatment:

Drug: Rabeprazole Sodium